ARTICLE SUMMARY:
The plethora of changes occurring in today’s healthcare environment have produced a broad range of challenges for medtech companies. Here two experts from the healthcare practice of Ernst & Young’s Parthenon Group outline a variety of strategies device companies can use to succeed in this new landscape or risk being overcome by change. By Dan Shoenholz and Keyuri Shah, Parthenon-EY Healthcare
The medical technology industry has been grappling with significant challenges for several years. Limited R&D productivity, pricing pressures, consolidation of payors and providers, and regulatory changes, such as shifts to value-based reimbursements, have pressured financial performance and are challenging traditional approaches to the business.
